GLP-1 medications work through a fundamentally different mechanismone that reduces appetite at the brain level rather than adding metabolic stress
Rodriguez-Viciana P, Warne PH, Dhand R et al (1994) Phosphatidylinositol-3-OH kinase direct target of Ras
Das S, Ganju A, Tiel RL, Kline DG
While oversights happen in IP services and third-party fee payment entities, oversights in fee payments are very rare In this situation, it is more likely that the realization that this patent was expiring in January of 2026 and Novo was not giving up much by deciding not to pay this fee. To simplify, think of Novos drugs as being protected by two locks in Canada
They will assess your medical history, discuss your goals, determine if Wegovy or Zepbound is appropriate for you, and create a personalized treatment plan